Live Updates > Live Update Details
2025-07-29 10:39:20
[Analysts: EU-US trade deal could increase pharmaceutical industry costs by up to $19 billion] Analysts say the EU-US trade deal could cost the pharmaceutical industry between $13 billion and $19 billion as branded drugs will be subject to a 15% tariff. One analyst said the increased costs could raise prices for consumers unless pharmaceutical companies take action to mitigate the impact of tariffs. Medicines have historically been tariff-free. By value, medicines are Europe's largest export to the United States, and the EU accounts for about 60% of all U.S. pharmaceutical imports. On Sunday, European officials said a bilateral trade agreement with an across-the-board 15% tariff includes medicines, with the exception of some generic drugs, which would not be subject to tariffs. The United States has been conducting a national security investigation into the pharmaceutical industry, which has been preparing for separate industry tariffs. U.S. President Trump said earlier this month, before negotiating a bilateral deal, that tariffs on medicines could be as high as 200%.
